Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (114,842)	$ (11,729)
Adjustments to reconcile net loss to net cash (used in)/provided by operating activities:
Depreciation and amortization	16,103	12,036
Stock-based compensation expense	84,696	0
Amortization of debt issuance costs	207	209
Non-cash lease expense	980	636
Amortization of capitalized commissions	1,514	2,044
Deferred taxes	(503)	(1,298)
Loss on equity investment	1,538	0
Other, net	5,789	(142)
Changes in operating assets and liabilities:
Accounts receivable, net	8,232	(613)
Inventories	(16,036)	8,962
Prepaid expenses and other current assets	11,125	2,819
Contract assets	(19,764)	(43,027)
Other long-term assets	(77)	(5)
Contract liabilities	(84,726)	(58,912)
Accounts payable and accrued expenses	22,965	10,668
Deferred commissions	(630)	(1,255)
Income taxes payable	(131)	0
Related party payables	0	626
Other long-term liabilities	71	83
Right-of-use assets and operating lease liabilities, net	(966)	(598)
Net cash (used in) operating activities	(84,455)	(79,496)
Cash flows from investing activities
Capital expenditures	(2,148)	(1,173)
Equity investments	(3,150)	0
Acquisition of business, net of cash acquired	(10,778)	0
Issuance of notes receivable	0	(2,500)
Proceeds from settlement of notes receivable	5,000	0
Net cash (used in) investing activities	(11,076)	(3,673)
Cash flows from financing activities
Proceeds from issuance of common stock in connection with the IPO, net of underwriting discounts and commissions	592,833	0
Payment of offering costs in connection with the IPO	(3,192)	0
Repayment of principal on long-term debt	(938)	0
Net cash used in financing activities	588,703	0
Net increase/(decrease) in cash and cash equivalents	493,172	(83,169)
Effect of exchange rate changes on cash	(52)	65
Cash and cash equivalents, beginning of period	162,573	104,656
Cash at end of period	655,693	21,552
Supplemental disclosures of cash flow information
Cash payments for interest	3,064	6,292
Cash (refunded)/paid for taxes	(14)	0
Supplemental disclosures of non-cash investing and financing activities:
Changes in accounts payable and accruals for purchases of fixed assets	1,343	358
Conversion of common units into shares of common stock upon IPO	1,135,718	0
Conversion of Class P Units into shares of common stock upon IPO	241,391	0
Issuance of common shares for acquisition of Orbion	$ 60,180	$ 0